GridAI Technologies Corp. operates in the energy orchestration and grid optimization software solutions space through its subsidiary Grid AI Corp., and continues legacy biopharmaceutical development activities focused on Adrulipase for the treatment of exocrine pancreatic insufficiency. The company serves energy infrastructure and healthcare markets.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.